For example, previous study described a 12-chemokine gene signature, and identified CCL19 as key chemokine for the maturation heterogeneity of tertiary lymphoid structures (TLS) in renal cell carcinoma, reflecting different TME immunological status and prognosis of cancers [10]. The gene discussed is CCL19; the disease is cancer.